Abstract Metabolic RNA labeling with high-throughput single-cell RNA sequencing (scRNA-seq) enables precise measurement of gene expression dynamics in complex biological processes, such as cell state transitions and embryogenesis. This technique, which tags newly synthesized RNA for detection through induced base conversions, relies on conversion efficiency, RNA integrity, and transcript recovery. These factors are influenced by the chosen chemical conversion method and platform compatibility. Despite its potential, a comprehensive comparison of chemical methods and platform compatibility has been lacking. Here, we benchmark ten chemical conversion methods using the Drop-seq platform, analyzing 52,529 cells. We find that on-beads methods, particularly the meta-chloroperoxy-benzoic acid/2,2,2-trifluoroethylamine combination, outperform in-situ approaches. To assess in vivo applications, we apply these optimized methods to 9883 zebrafish embryonic cells during the maternal-to-zygotic transition, identifying and experimentally validating zygotically activated transcripts, which enhanced zygotic gene detection capabilities. Additionally, we evaluate two commercial platforms with higher capture efficiency and find that on-beads iodoacetamide chemistry is the most effective. Our results provide critical guidance for selecting optimal chemical methods and scRNA-seq platforms, advancing the study of RNA dynamics in complex biological systems. Subject terms: Transcriptomics, Embryogenesis, Gene regulation __________________________________________________________________ Zhang, Peng, and colleagues benchmark metabolic RNA labelling chemistries for time-resolved single-cell RNA sequencing, improving in vivo detection of newly synthesized RNA during zebrafish embryogenesis. Introduction Single-cell RNA sequencing (scRNA-seq) has revolutionized our understanding of cellular heterogeneity and transcriptomic complexity. However, traditional scRNA-seq methods often fail to capture the temporal dynamics of RNA. Recent advances in time-resolved high-throughput scRNA-seq using metabolic labeling have provided deeper insights into RNA dynamics in complex biological processes^[52]1–[53]8. In metabolic labeling assays, nucleoside analogs, such as 4-Thiouridine (4sU)^[54]9–[55]15, 5-Ethynyluridine (5EU)^[56]16–[57]20, and 6-Thioguanosine (6sG)^[58]1,[59]21–[60]25, are rapidly incorporated into newly synthesized RNA, creating a chemical tag that can be detected via sequencing by identifying chemical-induced conversions. This strategy is applicable to a wide range of model organisms, including humans^[61]5,[62]26, mice^[63]2,[64]6, zebrafish^[65]7,[66]8,[67]27, and fruit flies^[68]14. Metabolic RNA labeling combined with scRNA-seq has significantly enhanced our ability to quantitatively analyze RNA synthesis and degradation. This approach has enabled key discoveries, such as understanding cell-cycle dynamics in cultured cells and organoids^[69]3,[70]4,[71]16,[72]26, tracking RNA during embryogenesis^[73]7,[74]8,[75]27,[76]28, investigating transcriptional bursting^[77]29, and identifying rapid transcriptional responses during viral infection^[78]1. Metabolic labeling involves several crucial steps: incorporating 4sU into newly synthesized RNA, performing chemical conversion reactions, and ensuring compatibility with high-throughput scRNA-seq platforms. Key chemical conversion methods include SLAM-seq^[79]1,[80]9, which uses an iodoacetamide (IAA)-based reaction; TimeLapse-seq^[81]2,[82]10, which utilizes 2,2,2-trifluoroethylamine (TFEA) with meta-chloroperoxy-benzoic acid (mCPBA)/sodium periodate (NaIO[4]) and NH[4]Cl-based reactions; and TUC-seq^[83]30, which involves osmium tetroxide (OsO[4]) and ammonium chloride (NH[4]Cl). These steps determine the assay’s efficiency, including conversion efficiencies as indicated by T-to-C substitution rates, and RNA recovery rates, indicated by the number of genes and transcripts detected per cell. Although statistical methods have been developed to correct some of these limitations^[84]2,[85]10,[86]12, improving 4sU labeling and T-to-C conversion efficiency at the experimental level remains crucial for achieving more reliable and consistent outcomes, advancing our understanding of RNA dynamics in various biological processes. Several methods have been developed to integrate metabolic labeling with high-throughput scRNA-seq platforms, such as scNT-seq^[87]2, scSLAM-seq^[88]1,[89]7, sci-fate^[90]3, sci-fate2^[91]4, 10× Genomics-based method^[92]8, and Well-TEMP-seq^[93]5,[94]6. These methods are built upon different scRNA-seq platforms, each with unique technical adaptations. For example, scNT-seq^[95]2 is based on the Drop-seq platform^[96]31 and leverages a microfluidic device, a strategy also implemented in the commercial 10× Genomics system^[97]32. Well-TEMP-seq^[98]5,[99]6 employs a microwell-based system, while sci-fate and sci-fate2 utilize the sci-RNA-seq approach^[100]3,[101]4,[102]33, which relies on multiple rounds of split-pool barcoding. The key distinction among these methods is the timing of chemical conversion, which occur either before or after single-cell encapsulation, potentially affecting conversion rates. scNT-seq^[103]2 relies on the home-brew Drop-seq platform^[104]31, while Well-TEMP-seq^[105]5,[106]6 relies on the Well-Paired-seq platform^[107]34, both of which use the same barcoded beads from Drop-seq and enable chemical conversion on naked capture RNA attached to barcoded beads after cell lysis. In contrast, sci-fate, sci-fate2 and 10× Genomics-based methods employ in-situ IAA-based chemical conversion within cells before mRNA releasing from the intact cell (Supplementary Fig. [108]1). Compared to the relatively low cell capture rate of the home-brew Drop-seq platform (~5%)^[109]31, in-situ IAA chemical conversion coupled with commercial platforms, such as 10× Genomics^[110]32 and MGI C4^[111]35, with higher capture rates (~50%)^[112]32 can be more effective for studying unique biological systems, such as early-stage embryos, where only a limited number of cells are available^[113]8. Although these methods have been demonstrated in different cell lines and biological systems, they vary in conversion efficiency, RNA recovery rate, and compatibility with scRNA-seq platforms^[114]2,[115]3. Given these differences and their potential impact on RNA dynamics analysis, a systematic and unbiased comparison of chemical conversion methods and their compatibility with different single-cell platforms is needed. To address this gap, we tested ten chemical conversion methods with varying reagent components and buffer conditions (Fig. [116]1a, b), including comparisons of in-situ and on-beads conditions using the same cell line. Our work provides direct comparisons and recommendations for time-resolved scRNA-seq methods using metabolic labeling. We further demonstrated that the recommended method effectively identifies zygotically activated transcripts in zebrafish embryogenesis. Additionally, we compared the 10× Genomics and MGI C4, two commercial single-cell platforms with high cell capture efficiency to the home-brew Drop-seq platform. The results highlight the strengths and weaknesses of each system, offering guidance for selecting the most appropriate chemical reaction and single-cell platform. Fig. 1. Experimental design for benchmarking chemical conversion methods. [117]Fig. 1 [118]Open in a new tab a Workflow for high-throughput scRNA-seq using metabolic labeling in ZF4 cells. ZF4 cells were labeled with 4-thiouridine (4sU, 100 μM), followed by cell dissociation and fixation. Chemical conversion was performed either before or after single-cell encapsulation on the Drop-seq platform. Newly synthesized transcripts were detected via sequencing by identifying chemical-induced T-to-C substitutions. b Summary of the ten chemical conversion methods evaluated in this study, including key parameters such as the main reagent, buffer pH, temperature, reaction time, and relevant references. “In-situ” refers